Understanding the Gleason Score: What Does It Mean for Prostate Cancer?

What Is the Gleason Score?

The Gleason score is a grading system used for prostate cancer. It is based on how closely the cancerous prostate tissue resembles normal prostate tissue when examined under a microscope.

A pathologist examines tissue obtained during a prostate biopsy and identifies the most common and the second most common cancer patterns.

Each pattern is assigned a grade, traditionally ranging from 1 to 5, based on how abnormal the cells and tissue architecture appear.

The two most significant patterns are then added together to produce the Gleason score.

For example:

The score provides information about the biological behaviour of the cancer and helps doctors estimate how likely it is to grow or spread.

Why Is the Gleason Score Important?

Not all prostate cancers behave in the same way.

Some prostate cancers grow slowly and may be monitored carefully without immediate treatment. Others can be more aggressive and may require active treatment.

The Gleason score provides one important piece of information that helps doctors determine where a patient's cancer falls along this spectrum.

It can help with:

However, doctors do not use the Gleason score alone. PSA levels, cancer stage, imaging findings, biopsy results and the patient's overall health are also important.

How Is the Gleason Score Calculated?

A prostate biopsy collects small samples of prostate tissue. These samples are examined by a pathologist.

The pathologist identifies the architectural patterns of the cancer and assigns grades to the relevant patterns.

The two most significant patterns are generally combined.

For example:

The order of the numbers matters.

A 3 + 4 cancer and a 4 + 3 cancer both have a total score of 7, but they may not carry exactly the same risk because the predominant pattern is different.

A larger proportion of pattern 4 disease generally indicates a more aggressive cancer than a tumour composed predominantly of pattern 3.

Does a Higher Gleason Score Mean More Aggressive Cancer?

Generally, yes.

A higher Gleason score means that the cancer cells have more abnormal architectural features and are more likely to behave aggressively.

Broadly:

However, it is important not to interpret the number in isolation.

A Gleason score is a grade, while the stage describes how far the cancer has spread.

Gleason Score vs Prostate Cancer Stage

These two terms are sometimes confused, but they describe different aspects of the disease.

Gleason Score

The Gleason score describes the appearance and aggressiveness of cancer cells under a microscope.

Cancer Stage

The stage describes how extensive the cancer is in the body.

For example, a prostate tumour may be confined to the prostate but have a high Gleason score. Conversely, a lower-grade tumour may sometimes be found at a more advanced stage.

Doctors use both grade and stage, along with PSA and other findings, to determine the overall risk and appropriate treatment.

What Is a Gleason Grade Group?

Modern prostate cancer reporting often uses Grade Groups in addition to or instead of simply reporting the Gleason score.

The Grade Group system ranges from 1 to 5:

This system can make it easier for patients to understand the relative grade of their cancer.

It is worth remembering that these are broad categories. Your individual risk depends on your complete clinical picture.

Is Gleason 6 Really Cancer?

Yes. A Gleason score of 6 represents prostate cancer.

However, Gleason 6 cancers are generally considered to be at the lower end of the prostate cancer grading spectrum and may behave less aggressively than higher-grade cancers.

Some men with low-risk prostate cancer may be offered active surveillance rather than immediate surgery or radiation.

Active surveillance does not mean ignoring the cancer. It involves regular monitoring through tests such as PSA testing, clinical evaluation, imaging and, when appropriate, repeat biopsy.

The purpose is to avoid or delay treatment-related side effects when the cancer is unlikely to cause harm in the near term, while still allowing treatment if signs of progression appear.

What Does Gleason 3+4 Mean?

A Gleason score of 3+4=7 means that pattern 3 is the predominant pattern, with some pattern 4 present.

This is generally considered different from 4+3=7, where pattern 4 is predominant.

Although both have a total Gleason score of 7, the proportion and significance of the higher-grade pattern can influence the overall risk assessment and treatment recommendation.

Your doctor may also consider the number and extent of positive biopsy cores, PSA level, imaging and clinical stage.

What Does Gleason 4+3 Mean?

A 4+3=7 tumour contains predominantly pattern 4 with a smaller amount of pattern 3.

Because pattern 4 is the dominant pattern, this is generally considered to carry a higher risk than 3+4=7.

Depending on the patient's other findings, active treatment may be recommended rather than surveillance.

What Do Gleason 8, 9 and 10 Mean?

Gleason scores of 8, 9 and 10 indicate higher-grade prostate cancer.

These cancers are more likely to grow and spread compared with lower-grade tumours.

Treatment may involve one or a combination of approaches, depending on whether the cancer is localised or has spread.

Potential treatments can include:

The exact treatment plan should be based on the cancer's stage, grade, PSA level, imaging and the patient's health.

How Does the Gleason Score Affect Treatment?

The Gleason score can influence treatment decisions, but it is only one part of the decision-making process.

Does the Gleason Score Determine Prognosis?

It provides important information about prognosis, but it does not determine the outcome by itself.

Doctors generally consider multiple factors, including:

This combined assessment gives a much clearer picture than looking at the Gleason score alone.

Why Your Biopsy Report Matters

A prostate biopsy report contains much more information than simply a Gleason number.

Your urologist may review:

Understanding the complete report is important before deciding on treatment.

If you have recently received a biopsy report, do not assume that a single number tells the entire story. Ask your urologist to explain what the findings mean in the context of your PSA, MRI and clinical stage.

When Should You See a Urologist?

Men should seek medical evaluation if they have symptoms or test results that raise concern about prostate disease.

Possible warning signs can include:

However, early prostate cancer often causes no symptoms.

This is why evaluation based on age, risk factors, family history and PSA testing may be important for appropriate individuals.

Finding the Right Care for Prostate Cancer

A prostate cancer diagnosis can feel overwhelming, particularly when medical reports contain terms such as PSA, Gleason score, Grade Group and clinical stage.

For men seeking specialised care for Prostate Cancer in Navi Mumbai, the first step is a detailed evaluation by an experienced urologist. The doctor can review the biopsy, PSA results and imaging to determine the cancer's risk category and discuss appropriate treatment options.

Depending on the diagnosis, treatment may involve active surveillance, surgery, radiation, hormone therapy or a combination of treatments.

Conclusion

The Gleason score is an important part of understanding prostate cancer. It describes how abnormal the cancer looks under a microscope and provides valuable information about how aggressively the cancer may behave.

However, the Gleason score is only one piece of the puzzle. PSA levels, Grade Group, tumour stage, MRI findings, biopsy details and overall health all contribute to treatment planning.

If you or a loved one has been diagnosed with prostate cancer or has an abnormal PSA or biopsy result, getting an expert evaluation can help you understand the diagnosis and available options.

Book an appointment with the experienced urology team at MITR Urology Associates to discuss your prostate cancer diagnosis, Gleason score and personalised treatment options.